203 related articles for article (PubMed ID: 15358215)
1. Runx3-/- gastric epithelial cells differentiate into intestinal type cells.
Fukamachi H; Ito K; Ito Y
Biochem Biophys Res Commun; 2004 Aug; 321(1):58-64. PubMed ID: 15358215
[TBL] [Abstract][Full Text] [Related]
2. In vitro differentiation of Runx3-/- p53-/- gastric epithelial cells into intestinal type cells.
Fukamachi H; Mimata A; Tanaka I; Ito K; Ito Y; Yuasa Y
Cancer Sci; 2008 Apr; 99(4):671-6. PubMed ID: 18377419
[TBL] [Abstract][Full Text] [Related]
3. Runx3 controls growth and differentiation of gastric epithelial cells in mammals.
Fukamachi H
Dev Growth Differ; 2006 Jan; 48(1):1-13. PubMed ID: 16466388
[TBL] [Abstract][Full Text] [Related]
4. Growth regulation of gastric epithelial cells by Runx3.
Fukamachi H; Ito K
Oncogene; 2004 May; 23(24):4330-5. PubMed ID: 15156189
[TBL] [Abstract][Full Text] [Related]
5. Expression of RUNX3 protein in human gastric mucosa, intestinal metaplasia and carcinoma.
Osaki M; Moriyama M; Adachi K; Nakada C; Takeda A; Inoue Y; Adachi H; Sato K; Oshimura M; Ito H
Eur J Clin Invest; 2004 Sep; 34(9):605-12. PubMed ID: 15379759
[TBL] [Abstract][Full Text] [Related]
6. RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization.
Ito K; Liu Q; Salto-Tellez M; Yano T; Tada K; Ida H; Huang C; Shah N; Inoue M; Rajnakova A; Hiong KC; Peh BK; Han HC; Ito T; Teh M; Yeoh KG; Ito Y
Cancer Res; 2005 Sep; 65(17):7743-50. PubMed ID: 16140942
[TBL] [Abstract][Full Text] [Related]
7. RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD.
Chi XZ; Yang JO; Lee KY; Ito K; Sakakura C; Li QL; Kim HR; Cha EJ; Lee YH; Kaneda A; Ushijima T; Kim WJ; Ito Y; Bae SC
Mol Cell Biol; 2005 Sep; 25(18):8097-107. PubMed ID: 16135801
[TBL] [Abstract][Full Text] [Related]
8. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers.
Sakakura C; Hasegawa K; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Hagiwara A
Clin Cancer Res; 2005 Sep; 11(18):6479-88. PubMed ID: 16166423
[TBL] [Abstract][Full Text] [Related]
9. Loss of RUNX3 expression correlates with differentiation, nodal metastasis, and poor prognosis of gastric cancer.
Hsu PI; Hsieh HL; Lee J; Lin LF; Chen HC; Lu PJ; Hsiao M
Ann Surg Oncol; 2009 Jun; 16(6):1686-94. PubMed ID: 19290488
[TBL] [Abstract][Full Text] [Related]
10. Claudin-1 has tumor suppressive activity and is a direct target of RUNX3 in gastric epithelial cells.
Chang TL; Ito K; Ko TK; Liu Q; Salto-Tellez M; Yeoh KG; Fukamachi H; Ito Y
Gastroenterology; 2010 Jan; 138(1):255-65.e1-3. PubMed ID: 19706291
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of growth of mouse gastric cancer cells by Runx3, a novel tumor suppressor.
Guo WH; Weng LQ; Ito K; Chen LF; Nakanishi H; Tatematsu M; Ito Y
Oncogene; 2002 Nov; 21(54):8351-5. PubMed ID: 12447699
[TBL] [Abstract][Full Text] [Related]
12. Tumor suppressor activity of RUNX3.
Bae SC; Choi JK
Oncogene; 2004 May; 23(24):4336-40. PubMed ID: 15156190
[TBL] [Abstract][Full Text] [Related]
13. Expression status of RUNX1/AML1 in normal gastric epithelium and its mutational analysis in microdissected gastric cancer cells.
Usui T; Aoyagi K; Saeki N; Nakanishi Y; Kanai Y; Ohki M; Ogawa K; Yoshida T; Sasaki H
Int J Oncol; 2006 Oct; 29(4):779-84. PubMed ID: 16964375
[TBL] [Abstract][Full Text] [Related]
14. [Reappraisal of the impacts of human Runt-related transcription factor gene 3 expression on differentiation and prognosis of gastric cancer].
Wu BW; Zhang J; Fei XF; Zhu ZG; Cao WX
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Mar; 10(2):165-8. PubMed ID: 17380460
[TBL] [Abstract][Full Text] [Related]
15. Causal relationship between the loss of RUNX3 expression and gastric cancer.
Li QL; Ito K; Sakakura C; Fukamachi H; Inoue Ki; Chi XZ; Lee KY; Nomura S; Lee CW; Han SB; Kim HM; Kim WJ; Yamamoto H; Yamashita N; Yano T; Ikeda T; Itohara S; Inazawa J; Abe T; Hagiwara A; Yamagishi H; Ooe A; Kaneda A; Sugimura T; Ushijima T; Bae SC; Ito Y
Cell; 2002 Apr; 109(1):113-24. PubMed ID: 11955451
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of the gastric tumor suppressor RUNX3 following H. pylori infection results in its localization to the cytoplasm.
Cinghu S; Goh YM; Oh BC; Lee YS; Lee OJ; Devaraj H; Bae SC
J Cell Physiol; 2012 Mar; 227(3):1071-80. PubMed ID: 21567391
[TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
18. GASDERMIN, suppressed frequently in gastric cancer, is a target of LMO1 in TGF-beta-dependent apoptotic signalling.
Saeki N; Kim DH; Usui T; Aoyagi K; Tatsuta T; Aoki K; Yanagihara K; Tamura M; Mizushima H; Sakamoto H; Ogawa K; Ohki M; Shiroishi T; Yoshida T; Sasaki H
Oncogene; 2007 Oct; 26(45):6488-98. PubMed ID: 17471240
[TBL] [Abstract][Full Text] [Related]
19. Runx3 expression during mouse tongue and palate development.
Yamamoto H; Ito K; Kawai M; Murakami Y; Bessho K; Ito Y
Anat Rec A Discov Mol Cell Evol Biol; 2006 Jul; 288(7):695-9. PubMed ID: 16761282
[TBL] [Abstract][Full Text] [Related]
20. Loss of RUNX3 expression significantly affects the clinical outcome of gastric cancer patients and its restoration causes drastic suppression of tumor growth and metastasis.
Wei D; Gong W; Oh SC; Li Q; Kim WD; Wang L; Le X; Yao J; Wu TT; Huang S; Xie K
Cancer Res; 2005 Jun; 65(11):4809-16. PubMed ID: 15930301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]